CCM
Copeland Capital Management Portfolio holdings
AUM
$4.86B
This Quarter Return
+6.26%
1 Year Return
+6.46%
3 Year Return
+51.07%
5 Year Return
+108.51%
10 Year Return
+304.97%
AUM
$1.71B
AUM Growth
+$1.71B
(+9.5%)
Cap. Flow
+$84.4M
Cap. Flow
% of AUM
4.94%
Top 10 Holdings %
Top 10 Hldgs %
19.79%
Holding
138
New
8
Increased
57
Reduced
65
Closed
2
Top Buys
| 1 |
CCMP
CMC Materials, Inc. Common Stock
CCMP
|
$15.7M |
| 2 |
CMD
Cantel Medical Corporation
CMD
|
$13.3M |
| 3 |
Exponent
EXPO
|
$11.8M |
| 4 |
Wyndham Hotels & Resorts
WH
|
$9.66M |
| 5 |
Cable One
CABO
|
$9.17M |
Top Sells
| 1 |
ABAX
Abaxis Inc
ABAX
|
$23.3M |
| 2 |
NewMarket
NEU
|
$8.79M |
| 3 |
Chemed
CHE
|
$6.52M |
| 4 |
The Ensign Group
ENSG
|
$5.41M |
| 5 |
American States Water
AWR
|
$5.34M |
Sector Composition
| 1 | Industrials | 16.32% |
| 2 | Healthcare | 16.26% |
| 3 | Financials | 14.28% |
| 4 | Technology | 12.57% |
| 5 | Consumer Discretionary | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Philip Morris
PM
$260B
| $513K | 0.03% | 6,358 +1,178 | +23% | +$95K |
|
127
Exxon Mobil
XOM
$487B
| $458K | 0.03% | 5,541 | – | – |
|
128
Novo Nordisk
NVO
$251B
| $444K | 0.03% | 9,635 | – | – |
|
129
AbbVie
ABBV
$372B
| $404K | 0.02% | 4,358 +160 | +4% | +$14.8K |
|
130
Johnson & Johnson
JNJ
$427B
| $334K | 0.02% | 2,751 +14 | +0.5% | +$1.7K |
|
131
3M
MMM
$82.8B
| $296K | 0.02% | 1,506 | – | – |
|
132
Pfizer
PFE
$141B
| $288K | 0.02% | 7,939 | – | – |
|
133
McDonald's
MCD
$224B
| $280K | 0.02% | 1,785 | – | – |
|
|
PX
134
DELISTED
Praxair Inc
PX
| $205K | 0.01% | +1,297 | New | +$205K |
|
135
Lazard
LAZ
$5.39B
| $203K | 0.01% | 4,142 +39 | +1% | +$1.91K |
|
136
Digital Realty Trust
DLR
$57.2B
| $201K | 0.01% | +1,804 | New | +$201K |
|
137
UGI
UGI
$7.44B
| – | – | -55,153 | Closed | -$2.45M |
|
|
ABAX
138
DELISTED
Abaxis Inc
ABAX
| – | – | -330,230 | Closed | -$23.3M |
|